Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease-Reference-Cited by-同舟云学术

Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease

Published:2022-11-03 Issue:8 Volume:22 Page:1285-1295
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Mendes Diana¹^ORCID,Averin Ahuva²^ORCID,Atwood Mark²,Sato Reiko³^ORCID,Vyse Andrew¹^ORCID,Campling James¹^ORCID,Weycker Derek²^ORCID,Slack Mary⁴^ORCID,Ellsbury Gillian¹^ORCID,Mugwagwa Tendai¹^ORCID

Affiliation:

1. Pfizer Ltd, Tadworth, UK

2. Policy Analysis Inc. (PAI), Chestnut Hill, MA, USA

3. Pfizer Inc, Collegeville, PA, USA

4. School of Medicine & Dentistry, Griffith University, Gold Coast Campus, 4222, Australia

Funder

This study was funded by Pfizer Inc

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2022.2134120

Reference90 articles.

1. Community-acquired pneumonia in the United Kingdom: a call to action

2. Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales

3. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

4. Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014–2018

5. Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Vaccines for Chronic Respiratory Patients;Archivos de Bronconeumología;2024-09

2. The impact and cost-effectiveness of pneumococcal immunisation strategies for the elderly in England;Vaccine;2024-07

3. Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan;Expert Review of Vaccines;2024-05-09

4. Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults;Infectious Diseases and Therapy;2024-05-03

5. Nasal Staphylococcus aureus Carriage and Antimicrobial Resistance Profiles Among Community-Dwelling Adults in Jiangsu, China;Infectious Diseases and Therapy;2024-05-03